Skip to main content
Fig. 1 | World Journal of Surgical Oncology

Fig. 1

From: Higher titer hepatitis B core antibody predicts a higher risk of liver metastases and worse survival in patients with colorectal cancer

Fig. 1

Kaplan–Meier curves of overall survival (OS), time to progress (TTP), and hepatic metastasis-free survival (HMFS) between the anti-HBc positive group and anti-HBc negative group. A Overall survival curve. B Time to progress curve. C Hepatic metastasis-free survival curve. The light blue and red area represent 95% confidence intervals of each group. There is no significant difference between the two groups

Back to article page

World Journal of Surgical Oncology

ISSN: 1477-7819

Contact us